SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (14627)9/16/2000 8:10:14 PM
From: Bluegreen  Respond to of 17367
 
Cacaito, can we count on you to help kids with Meningococcemia get Neuprex IMMEDIATELY???? Any emails to major news organizations would help. 70% reduction in severe amputations is MORE than enough for approval under Subpart E. Will you help? You know it is the RIGHT thing to do. You of all people know the true power of Neuprex when given at the proper time.



To: Cacaito who wrote (14627)9/16/2000 11:00:46 PM
From: aknahow  Read Replies (1) | Respond to of 17367
 
Cacaito, I think you are honest. I believe you misunderstood wht XOMA said. The subjects all were Glasgow 8 or higher. About 80% of these 8 or higher fell in the first grop of 8 - 11 or 12. Don't remember the exact breakpoin for the 12 to 15 group. Your mind remembers this as taking the low. I won't bug you about this. It happens to everyone. but check it out. Think about it before you post this again. Thanks.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News